Sigilon Therapeutics logo
Sigilon Therapeutics SGTX

Quartalsbericht 2023-Q2
hinzugefügt 07.08.2023

report update icon

Sigilon Therapeutics Langfristiger Schuldenstrom 2011-2026 | SGTX

Langfristiger Schuldenstrom Jährlich Sigilon Therapeutics

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
4.48 M 4.84 M - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
4.84 M 4.48 M 4.66 M

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 0.88 -1.69 % $ 6.47 M chinaChina
Aquestive Therapeutics Aquestive Therapeutics
AQST
631 K $ 4.1 1.23 % $ 438 M usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
9.96 M $ 22.45 1.13 % $ 3.72 B usaUSA
Athira Pharma Athira Pharma
ATHA
465 K - - $ 269 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
Atreca Atreca
BCEL
3.54 M - -11.76 % $ 5.79 M usaUSA
Berkeley Lights Berkeley Lights
BLI
3.29 M - -7.31 % $ 87 M usaUSA
Calithera Biosciences Calithera Biosciences
CALA
1.37 M - -10.95 % $ 876 K usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
7 K - - $ 3.45 B usaUSA
ChemoCentryx ChemoCentryx
CCXI
2.81 M - - $ 3.74 B usaUSA
Cerus Corporation Cerus Corporation
CERS
2.9 M $ 2.03 5.73 % $ 387 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
137 K - -16.75 % $ 25.8 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
BioNTech SE BioNTech SE
BNTX
45 M $ 103.45 1.85 % $ 27.2 B germanyGermany
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
208 K - -2.5 % $ 5.88 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
3.5 M - - $ 2.18 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
4.18 M - - $ 2.02 B usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
Editas Medicine Editas Medicine
EDIT
6.03 M $ 3.0 6.38 % $ 266 M usaUSA
Edesa Biotech Edesa Biotech
EDSA
19.9 K $ 18.27 14.94 % $ 58.4 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 3.19 6.69 % $ 5.25 M israelIsrael
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
84 K - -9.21 % $ 2.55 M usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
712 K - -5.68 % $ 8.28 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA